Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Sep 27, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help doctors in Nigeria diagnose breast cancer more effectively. The main goal is to train radiologists—doctors who specialize in looking at images of the body—to perform a procedure called ultrasound-guided breast biopsies. This involves using a special device to look at the breast and safely take a small sample of tissue that can be tested for cancer. By using mobile health technology, the researchers aim to create a practical and sustainable training method for these doctors.

If you are a woman aged 18 or older and have had a breast ultrasound that shows a solid mass suspicious for cancer, you may be eligible to participate in this study. Participants will receive training and support throughout the process. It’s important to note that you would need to agree to take part in the trial by signing a consent form. This study is currently recruiting participants, and your involvement could help improve breast cancer diagnosis in Nigeria.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age 18 and older female.
• • Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis.
• Exclusion Criteria:
• • Participants unwilling to sign consent.
• • Participants under the age of 18.